New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 21, 2014
13:05 EDTECYTEndocyte price target raised to $46 from $22 at RBC Capital
News For ECYT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 22, 2014
07:24 EDTECYTEndocyte risk/reward favorable, says RBC Capital
RBC Capital says that Endocyte's stock will rise to $15 in the most likely scenario, while the shares could jump to $31 in a bullish scenario. The firm says the company's Phase III assets have a 65% chance of succeeding.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use